Zosano Pharma Corporation is a biopharmaceutical company that specializes in developing innovative products for patients who have limited access to existing therapies. Their transdermal microneedle system technology is designed to deliver approved molecules quickly and safely to patients through titanium microneedles coated with medication. Their lead product candidate is Qtrypta™ (M207), a proprietary formulation of zolmitriptan that is delivered via their transdermal microneedle system technology for acute migraine treatments.
Zosano Pharma Corporation's ticker is ZSAN
The company's shares trade on the NASDAQ stock exchange
They are based in Fremont, California
There are 51-200 employees working at Zosano Pharma Corporation
It is https://www.zosanopharma.com/
Zosano Pharma Corporation is in the Healthcare sector
Zosano Pharma Corporation is in the Biotechnology industry
The following five companies are Zosano Pharma Corporation's industry peers: